Kimberlee C. Drapkin - 21 Mar 2024 Form 4 Insider Report for LENZ Therapeutics, Inc. (LENZ)

Role: Director
Signature: /s/ Evert Schimmelpennink, as Attorney-in-Fact
Issuer symbol: LENZ
Transactions as of: 21 Mar 2024
Net transactions value: $0
Form type: 4
Filing time: 25 Mar 2024, 20:39:32 UTC
Previous filing: 01 Aug 2023
Next filing: 10 Jun 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LENZ	Stock Option (right to buy)	Award	$0	+27,000		$0.000000	27,000	21 Mar 2024	Common Stock	27,000	$15.05	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2024 Equity Incentive Plan) through each applicable date, one thirty-sixth (1/36th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 21, 2024.

Content

Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2024 Equity Incentive Plan) through each applicable date, one thirty-sixth (1/36th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 21, 2024.

Remarks:

Exhibit 24 - Power of Attorney